ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

2 links0 made here, not in the record6 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.govReplaced, or read an older version
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT05753592A Study to Investigate thePharmacokinetics and Safetyof Remibrutinib inParticipants With HepaticImpairment Compared WithMatched HealthyParticipantsNovartis PharmaceuticalsPhase 1 · completedRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 5 · ClinicalTrials.gov record · Version of 2026-11-05Nov 5 · Rule based · Reading set asideNov 16 · Rule based · Read againRead againCONDITIONSHepatic ImpairmentNo longer in the registry's filing›Nov 14 · Rule based · Not readNot readDRUGSRemibrutinibEntry “Part 1; LOU064 (Remibrutinib)”…›Nov 4 · Claude Opus 5.5 · TestedNov 16 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Remibrutinib

From the registry record3 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Part 1; LOU064 (Remibrutinib)”the record gives no role
→judged=agrees=agrees
How the 3 judgments split100%of judgments with a known value say Tested
Tested · 3

All judgments on this study

WhenLinkJudgeDecisionState
Nov 4RemibrutinibClaude Opus 5.5TestedReplaced
Nov 5The record itselfClinicalTrials.gov recordVersion of 2026-11-05Record change
Nov 5The record itselfRule based · nightly checkReading set asideCurrent
Nov 14Hepatic ImpairmentRule based · condition-kind ruleNot readCurrent
Nov 16The record itselfRule based · nightly checkRead againCurrent
Nov 16RemibrutinibClaude Opus 5.5TestedCurrent
Nov 18RemibrutinibRule based · role ruleTestedAgrees

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.

When a study changes after it was read

Every night, studies whose record changed are compared with the last reading. A change to sites or dates leaves the reading as it is; a reworded entry keeps it; a change to the treatments or conditions marks it to be read again.

Until it is read again, the page shows the last reading and says so.